☰

Chih-Pin(Max) Chuu, PhD - Publications

Affiliations: 
Institute of Cellular and Systems Biology Taiwan National Health Research Institutes 
Area:
Prostate Cancer, Protein mechanisms of bioactive natural products,
Website:
http://core.nhri.org.tw/encore/webcont!Cont.action?news_id=201107131310546215812&lab_id=pccore
Tree Info Similar researchers PubMed Report error

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tseng LL, Cheng HH, Yeh TS, Huang SC, Syu YY, Chuu CP, Yuh CH, Kung HJ, Wang WC. Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 32958674 DOI: 10.1073/Pnas.1919766117  0.384
2020 Siao AC, Lin YY, Shih LJ, Tsuei YW, Chuu CP, Kuo YC, Kao YH. Endothelin-1 stimulates preadipocyte growth via the PKC, STAT3, AMPK, c-JUN, ERK, sphingosine kinase, and sphingomyelinase pathways. American Journal of Physiology. Cell Physiology. PMID 32755450 DOI: 10.1152/Ajpcell.00491.2019  0.344
2020 Lin CY, Chuu CP. New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer. Translational Andrology and Urology. 9: 837-839. PMID 32420195 DOI: 10.21037/Tau.2020.03.24  0.31
2020 Tseng JC, Huang SH, Lin CY, Wang BJ, Huang SF, Shen YY, Chuu CP. ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis. Cell Death & Disease. 11: 376. PMID 32415173 DOI: 10.1038/S41419-020-2587-9  0.447
2019 Kuo YY, Huo C, Lin CY, Lin HP, Liu JS, Wang WC, Chang CR, Chuu CP. Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213. Cell Communication and Signaling : Ccs. 17: 100. PMID 31429764 DOI: 10.1186/S12964-019-0404-9  0.443
2019 Lai CJ, Lin CY, Liao WY, Hour TC, Wang HD, Chuu CP. CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling. Cells. 8. PMID 30935014 DOI: 10.3390/Cells8040295  0.332
2019 Chuu C, Lin C, Huang S, Tsai KK-. ACTL6A is a novel oncogene and prognostic biomarker for prostate cancer Annals of Oncology. 30: vi106. DOI: 10.1093/Annonc/Mdz338.069  0.399
2018 Chuu C, Lin C, Wang B, Chen B, Tseng J. Histone demethylase KDM4C is a novel oncogene and prognostic biomarker for prostate cancer Annals of Oncology. 29: vii54-vii55. DOI: 10.1093/Annonc/Mdy374.016  0.327
2017 Lai CJ, Cheng HC, Lin CY, Huang SH, Chen TH, Chung CJ, Chang CH, Wang HD, Chuu CP. Activation of liver X receptor suppresses angiogenesis via induction of ApoD. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28842423 DOI: 10.1096/Fj.201700374R  0.34
2016 Lin CY, Chuu CP. Friend or foe: role of E-cadherin in prostate cancer metastasis. Translational Andrology and Urology. 5: 961-963. PMID 28078231 DOI: 10.21037/Tau.2016.11.08  0.334
2016 Tseng JC, Lin CY, Su LC, Fu HH, Yang SD, Chuu CP. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling. Oncotarget. PMID 27191743 DOI: 10.18632/Oncotarget.9380  0.419
2015 Huo C, Kao YH, Chuu CP. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells. Cancer Letters. 369: 103-11. PMID 26297988 DOI: 10.1016/J.Canlet.2015.08.001  0.368
2015 Huang JH, Lin CY, Wu SY, Chen WY, Chu CL, Brown GD, Chuu CP, Wu-Hsieh BA. CR3 and Dectin-1 Collaborate in Macrophage Cytokine Response through Association on Lipid Rafts and Activation of Syk-JNK-AP-1 Pathway. Plos Pathogens. 11: e1004985. PMID 26132276 DOI: 10.1371/Journal.Ppat.1004985  0.323
2015 Kuo YY, Jim WT, Su LC, Chung CJ, Lin CY, Huo C, Tseng JC, Huang SH, Lai CJ, Chen BC, Wang BJ, Chan TM, Lin HP, Chang WS, Chang CR, Chuu CP, et al. Caffeic Acid Phenethyl Ester Is a Potential Therapeutic Agent for Oral Cancer. International Journal of Molecular Sciences. 16: 10748-10766. PMID 25984601 DOI: 10.3390/Ijms160510748  0.375
2015 Chuu C, Lin C, Tsai KK. Proteomics profiling of epigenetic proteins during acinar morphogenesis to identify prostate cancer prognostic markers Annals of Oncology. 26: vii122. DOI: 10.1093/Annonc/Mdv472.75  0.356
2014 Kokontis JM, Lin HP, Jiang SS, Lin CY, Fukuchi J, Hiipakka RA, Chung CJ, Chan TM, Liao S, Chang CH, Chuu CP. Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2. Plos One. 9: e109170. PMID 25271736 DOI: 10.1371/Journal.Pone.0109170  0.402
2014 Leung KK, Hause RJ, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome. Molecular & Cellular Proteomics : McP. 13: 1705-23. PMID 24728074 DOI: 10.1074/Mcp.M113.034876  0.668
2014 Kokontis JM, Lin HP, Jiang SS, Lin CY, Fukuchi J, Hiipakka RA, Chung CJ, Chan TM, Liao S, Chang CH, Chuu CP. Correction: Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2 (PLoS ONE (2014) 9, 10 (e109170) DOI: 10.1371/journal.pone.0109170) Plos One. 9. DOI: 10.1371/Journal.Pone.0111731  0.39
2013 Lin CY, Huo C, Kuo LK, Hiipakka RA, Jones RB, Lin HP, Hung Y, Su LC, Tseng JC, Kuo YY, Wang YL, Fukui Y, Kao YH, Kokontis JM, Yeh CC, ... Chuu CP, et al. Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells. Plos One. 8: e65734. PMID 23785446 DOI: 10.1371/journal.pone.0065734  0.495
2013 Shu CL, Jing-Yang-Lai, Su LC, Chuu CP, Fukui Y. SWAP-70: a new type of oncogene. Plos One. 8: e59245. PMID 23555004 DOI: 10.1371/Journal.Pone.0059245  0.346
2013 Lin HP, Lin CY, Liu CC, Su LC, Huo C, Kuo YY, Tseng JC, Hsu JM, Chen CK, Chuu CP. Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling. International Journal of Molecular Sciences. 14: 5264-83. PMID 23466879 DOI: 10.3390/Ijms14035264  0.395
2013 Liu CC, Hsu JM, Kuo LK, Chuu CP. Caffeic acid phenethyl ester as an adjuvant therapy for advanced prostate cancer. Medical Hypotheses. 80: 617-9. PMID 23462369 DOI: 10.1016/J.Mehy.2013.02.003  0.379
2013 Shu C, Lai J, Su L, Chuu C, Fukui Y. Abstract 3018A: A novel type of oncogene SWAP-70. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-3018A  0.376
2012 Hause RJ, Leung KK, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors. Plos One. 7: e44471. PMID 22973453 DOI: 10.1371/Journal.Pone.0044471  0.671
2012 Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ, Hiipakka RA, Liao S, Jones RB. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Cancer Prevention Research (Philadelphia, Pa.). 5: 788-97. PMID 22562408 DOI: 10.1158/1940-6207.Capr-12-0004-T  0.735
2012 Lin HP, Jiang SS, Chuu CP. Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells. Plos One. 7: e31286. PMID 22347457 DOI: 10.1371/Journal.Pone.0031286  0.432
2012 Lin HP, Kuo LK, Chuu CP. Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells. Phytotherapy Research : Ptr. 26: 122-6. PMID 21567511 DOI: 10.1002/Ptr.3523  0.379
2012 Lin C, Huo C, Lin H, Jiang SS, Chuu C. Abstract 1276: Application of high-throughput proteomics Micro-Western array in studying molecular mechanism of anticancer effect of liver X receptor agonists against human colon cancer cells Cancer Research. 72: 1276-1276. DOI: 10.1158/1538-7445.Am2012-1276  0.459
2011 Chuu CP, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, Huo C, Su LC. Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer. Journal of Biomedical Science. 18: 63. PMID 21859492 DOI: 10.1186/1423-0127-18-63  0.388
2011 Chuu CP, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, Huo C, Huo C, Su LC, Liao S. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc. Cancer Science. 102: 2022-8. PMID 21781227 DOI: 10.1111/J.1349-7006.2011.02043.X  0.39
2011 Chuu CP. Modulation of liver X receptor signaling as a prevention and therapy for colon cancer. Medical Hypotheses. 76: 697-9. PMID 21333456 DOI: 10.1016/J.Mehy.2011.01.037  0.458
2011 Lin C, Huo C, Lin H, Jiang SS, Chiang C, Chuu C. Abstract C91: Systematically analyzing molecular mechanism of growth inhibition induced by liver × receptor agonists in HT-29 human colon cancer cells using high-throughput micro-Western array and microarray. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C91  0.413
2010 Ciaccio MF, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB. Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nature Methods. 7: 148-55. PMID 20101245 DOI: 10.1038/Nmeth.1418  0.755
2009 Chuu CP, Chen RY, Kokontis JM, Hiipakka RA, Liao S. Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Letters. 275: 86-92. PMID 18977589 DOI: 10.1016/J.Canlet.2008.10.001  0.383
2008 Chuu CP, Chen RY, Barkinge JL, Ciaccio MF, Jones RB. Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective. Molecular Cancer Research : McR. 6: 885-91. PMID 18567793 DOI: 10.1158/1541-7786.Mcr-07-0369  0.689
2007 Chuu CP, Chen RY, Hiipakka RA, Kokontis JM, Warner KV, Xiang J, Liao S. The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells. Biochemical and Biophysical Research Communications. 357: 341-6. PMID 17416342 DOI: 10.1016/J.Bbrc.2007.03.116  0.406
2007 Chuu CP, Kokontis JM, Hiipakka RA, Liao S. Modulation of liver X receptor signaling as novel therapy for prostate cancer. Journal of Biomedical Science. 14: 543-53. PMID 17372849 DOI: 10.1007/S11373-007-9160-8  0.439
2006 Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY, Liao S. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Research. 66: 6482-6. PMID 16818617 DOI: 10.1158/0008-5472.Can-06-0632  0.415
2005 Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity. The Prostate. 65: 287-98. PMID 16015608 DOI: 10.1002/Pros.20285  0.384
2005 Chuu CP, Hiipakka RA, Fukuchi J, Kokontis JM, Liao S. Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice. Cancer Research. 65: 2082-4. PMID 15781616 DOI: 10.1158/0008-5472.Can-04-3992  0.358
2004 Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP, Liao S. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Research. 64: 7686-9. PMID 15520170 DOI: 10.1158/0008-5472.Can-04-2332  0.416
Show low-probability matches.